Skip to main content
. 2020 Dec 21;64(1):26–41. doi: 10.1021/acs.jmedchem.0c00931

Figure 8.

Figure 8

Design of dual GSK-3β/HDACs inhibitors. The phthalimide moiety, which interacts with the ATP-binding site of GSK-3β, and an hydroxamic acid, which chelates the Zn2+ located in the HDAC active site, were linked through an alkylthiourea chain.